Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Globus Medical, Inc. GMED
$56.47
-$0.96 (-1.71%)
На 18:00, 12 мая 2023
+45.21%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
5775978821.00000000
-
week52high
80.04
-
week52low
50.92
-
Revenue
1022843000
-
P/E TTM
31
-
Beta
1.05674700
-
EPS
1.80000000
-
Last Dividend
0.00000000
-
Next Earnings Date
04 мая 2023 г. в 20:00
Описание компании
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Piper Sandler | Overweight | Overweight | 05 авг 2022 г. |
| Truist Securities | Buy | Buy | 20 июл 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 15 июл 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 12 мая 2022 г. |
| Wells Fargo | Overweight | Overweight | 11 мая 2022 г. |
| Barclays | Overweight | 18 окт 2022 г. | |
| Jefferies | Buy | 12 окт 2022 г. | |
| Morgan Stanley | Equal-Weight | Equal-Weight | 11 окт 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 09 ноя 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 06 янв 2023 г. |
| Truist Securities | Buy | Buy | 20 дек 2022 г. |
| Wells Fargo | Overweight | Overweight | 12 дек 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Lemaitre Dan | D | 0 | 5250 | 27 янв 2023 г. |
| Lemaitre Dan | A | 5250 | 5250 | 27 янв 2023 г. |
| RHOADS ANN D | D | 0 | 7500 | 27 янв 2023 г. |
| RHOADS ANN D | A | 22884 | 7500 | 27 янв 2023 г. |
| Huller Kelly | D | 0 | 7500 | 01 дек 2022 г. |
| Huller Kelly | D | 0 | 7500 | 01 дек 2022 г. |
| Huller Kelly | A | 7500 | 7500 | 01 дек 2022 г. |
| Lemaitre Dan | D | 17500 | 7500 | 25 авг 2022 г. |
| Lemaitre Dan | D | 14000 | 6000 | 25 авг 2022 г. |
| Lemaitre Dan | D | 10500 | 4500 | 25 авг 2022 г. |
Новостная лента
Globus Medical (GMED) Q1 Earnings Beat, Operating Margin Dips
Zacks Investment Research
05 мая 2023 г. в 14:27
The significant year-over-year surge in Globus Medical's (GMED) Enabling Technologies sales is driven by ongoing demand for the company's robotics and imaging system technologies.
Globus Medical, Inc. (GMED) Q1 2023 Earnings Call Transcript
Seeking Alpha
04 мая 2023 г. в 23:00
Globus Medical, Inc. (NYSE:GMED ) Q1 2023 Earnings Conference Call May 4, 2023 4:30 PM ET Company Participants Brian Kearns - Senior Vice President of Business Development and Investor Relations Dan Scavilla - President and CEO Keith Pfeil - Senior Vice President and Chief Financial Officer Conference Call Participants Mike Miksic - Barclays Shagun Singh - RBC David Saxon - Needham & Co Sam Dane - BTIG Kyle Rose - Canaccord Vik Chopra - Wells Fargo Operator Welcome to Globus Medical's First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.
Globus Medical (GMED) Surpasses Q1 Earnings and Revenue Estimates
Zacks Investment Research
04 мая 2023 г. в 20:30
Globus Medical (GMED) came out with quarterly earnings of $0.53 per share, beating the Zacks Consensus Estimate of $0.51 per share. This compares to earnings of $0.42 per share a year ago.
Globus Medical: Still Very Attractive After NuVasive Selloff
Seeking Alpha
04 мая 2023 г. в 05:41
Globus Medical caught headlines after announcing the NuVasive merger. Investors have wiped out considerable equity post-announcement, but the worst may be now priced in.
Globus Medical Schedules First Quarter Earnings Release and Conference Call
GlobeNewsWire
19 апр 2023 г. в 17:15
AUDUBON, Pa., April 19, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended March 31, 2023 after the market close on Thursday, May 4, 2023. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com.